Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
Xiaoying Ma(Hansoh Pharma (China)), Yuanfeng Zhou(Children's Hospital of Fudan University)
Cited by 5
Related Papers
Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity
|International Journal of Biological Sciences|2018|35
Breast cancer pre-clinical screening using infrared thermography and artificial intelligence: a prospective, multicentre, diagnostic accuracy cohort study
|International Journal of Surgery|2023|26
Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination
|OncoTargets and Therapy|2018|15
Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study
|American Journal of Nephrology|2022|15
Cut-off values of haemoglobin and clinical outcomes in incident peritoneal dialysis: the PDTAP study
|Nephrology Dialysis Transplantation|2023|9